Theranostic platform combines cisplatin, nanoparticles, and fluorescence to improve treatment delivery and diagnosis.
CAR-T cell therapy has been transforming the treatment of hematological neoplasms, but its implementation in countries such as Brazil still faces significant barriers.
This content is in Portuguese.
This content is in Portuguese.
This content is in Portuguese.
Agreements with major international publishers eliminate article processing charges and expand open-access publishing for Brazilian institutions.
This content is in Portuguese.
This content is in Portuguese.
The course will be offered from January 20 to April 30, 2026. Course registrations will close at noon on January 19, 2026.
This content is in Portuguese.
With lectures, collaborative activities, and a scientific ideation workshop, the event promoted the integration of competencies across USP, presented ongoing research, established the basis for the strategic planning of the C2PO, and reinforced the center’s role as an articulator of precision oncology initiatives within the university.
Letters of intent must be submitted by January 22, 2026.